EIM
ATRS

Essex Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

Essex Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-791,313
Closed -$2.6M – 517
2019
Q2 		$2.6M Buy
791,313
+118,776
+18% +$344K 0.36% 82
2019
Q1 		$2.04M Buy
672,537
+166,237
+33% +$539K 0.3% 100
2018
Q4 		$1.38M Buy
+506,300
New +$1.67M 0.22% 144

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $535M AUM 19.4% 1-Year Est. Return

Essex Investment Management's ATRS Position: Q3 2019 in Review

Essex Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q3 2019, closing a stake of 791,313 shares — an estimated $2.6M sold.

Essex Investment Management first reported a position in ATRS in Q4 2018 and held it in 3 quarters. The position peaked at $2.6M in Q2 2019. 135 funds tracked by Wall St. Rank hold ATRS as of Q3 2019.

  • Essex Investment Management reported no remaining Antares Pharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • Essex Investment Management sold 791,313 Antares Pharma, Inc. shares in Q3 2019, an estimated $2.6M.
  • Essex Investment Management first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 3 quarters.
  • Essex Investment Management's Antares Pharma, Inc. position peaked at $2.6M in Q2 2019.
  • 135 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2019.

Based on Essex Investment Management's 13F filing for Q3 2019, filed 22 Oct 2019.